Whole-genome analysis informs breast cancer response to aromatase inhibition
Matthew J. Ellis(Washington University in St. Louis), Li Ding(Washington University in St. Louis), Dong Shen(Washington University in St. Louis), Jingqin Luo(Breast Cancer Research Foundation), Vera J. Suman(Mayo Clinic), John W. Wallis(Washington University in St. Louis), Brian Andrew Van Tine(Washington University in St. Louis), Jeremy Hoog(Washington University in St. Louis), Reece Goiffon(Washington University in St. Louis), Theodore C. Goldstein(University of California, Santa Cruz), Sam Ng(University of California, Santa Cruz), Lin Li(Washington University in St. Louis), Robert J. Crowder(Washington University in St. Louis), Jacqueline Snider(Washington University in St. Louis), Karla V. Ballman(Mayo Clinic), Jason D. Weber(Washington University in St. Louis), Ken Chen(The University of Texas MD Anderson Cancer Center), Daniel C. Koboldt(Washington University in St. Louis), Cyriac Kandoth(Washington University in St. Louis), William Schierding(Washington University in St. Louis), Joshua F. McMichael(Washington University in St. Louis), Christopher A. Miller(Washington University in St. Louis), Charles Lu(Washington University in St. Louis), Christopher Harris(Washington University in St. Louis), Michael D. McLellan(Washington University in St. Louis), Michael C. Wendl(Washington University in St. Louis), Katherine DeSchryver(Washington University in St. Louis), D. Craig Allred(Breast Cancer Research Foundation), Laura J. Esserman(University of California, San Francisco), Gary Unzeitig(Doctors Hospital of Laredo), Julie A. Margenthaler(Washington University in St. Louis), Gildy V. Babiera(The University of Texas MD Anderson Cancer Center), P. Kelly Marcom(Duke University), J. Michael Guenther(Good Samaritan Hospital), Marilyn Leitch(Harold C. Simmons Comprehensive Cancer Center), Kelly K. Hunt(The University of Texas MD Anderson Cancer Center), John A. Olson(Duke University), Tao Yu(Washington University in St. Louis), Christopher A. Maher(Washington University in St. Louis), Lucinda Fulton(Washington University in St. Louis), Robert S. Fulton(Washington University in St. Louis), Michelle Harrison(Washington University in St. Louis), Ben Oberkfell(Washington University in St. Louis), Feiyu Du(Washington University in St. Louis), Ryan Demeter(Washington University in St. Louis), Tammi L. Vickery(Washington University in St. Louis), Adnan Elhammali(Washington University in St. Louis), Helen Piwnica‐Worms(Washington University in St. Louis), Sandra McDonald(Washington University in St. Louis), Mark A. Watson(Washington University in St. Louis), David J. Dooling(Washington University in St. Louis), David M. Ota(Duke University), Li-Wei Chang(Breast Cancer Research Foundation), Ron Bose(Breast Cancer Research Foundation), Timothy J. Ley(Washington University in St. Louis), David Piwnica‐Worms(Washington University in St. Louis), Joshua M. Stuart(University of California, Santa Cruz), Richard K. Wilson(Washington University in St. Louis), Elaine R. Mardis(Washington University in St. Louis)
Cited by 1,032Open Access
Abstract
Related Papers
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella et al.|New England Journal of Medicine|2004|11.5k